CRYSTAL HOOD: Open Payments
NPI 1245930577 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 18 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 2 | $68 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Alkermes, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
Products named: ABILIFY MAINTENA, QULIPTA, VRAYLAR, HETLIOZ, FANAPT, LEQVIO, SPRAVATO, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
